Objective: To examine the potential interactive relations of central versus total obesity and blood pressure (BP) to cognitive function. Method: In all, 90 healthy, stroke, and dementia-free middle-aged and older adults (ages 54-81 years; 63% male; 93% White) underwent biomedical and neuropsychological assessment. Relations of central obesity (assessed by waist circumference (WC)) and systolic or diastolic BP to cognitive function were examined in multiple regression models. Next, body mass index (BMI) was substituted for WC in the models. Results: After statistical adjustment for age, education, gender, and other potential confounders including components of the metabolic syndrome (depending on the model), significant interactions of WC and systolic (or diastolic) BP were noted for the Grooved Pegboard -Dominant Hand and Stroop Interference scores, with marginally significant results for Grooved PegboardNondominant Hand. In general, individuals with greater WC and higher BP performed most poorly on these measures. Similar results were obtained for BMI. Conclusion: Independent of other confounders including facets of the metabolic syndrome, the combination of greater WC (or BMI) and higher (systolic or diastolic) BP was associated with diminished performance on tests of motor speed and manual dexterity, and executive function (i.e. response inhibition) accounting for 3-13% of the variance in these measures. In healthy older adults, there are similar, negative relations of central and total obesity to cognitive function that are potentiated by higher BP levels.
Introduction
The extent to which the brain is a target organ of obesity, independent of other cardiovascular risk factors, has been controversial. Although findings have been mixed, recent data suggest that obesity is independently related to an increased risk of both ischemic and hemorrhagic stroke. [1] [2] [3] Obesity has also been suggested as a risk factor for vascular dementia and Alzheimer's disease. 4, 5 Obesity has been associated with poorer cognitive function in several population-based investigations. [6] [7] [8] However, two of these studies did not control for major confounding variables such as other cardiovascular risk factors and cardiovascular or metabolic diseases. 6, 7 Examining participants from the Framingham Study who were free of stroke, dementia, or diagnosed cardiovascular disease, Elias et al. 8 reported that obese men performed significantly more poorly than nonobese men across several tests of memory and executive function after controlling for multiple confounding variables. 8 Furthermore, significant cumulative effects of obesity and hypertension were noted on several memory measures. Obesity is strongly related to higher blood pressure (BP) or hypertension. 9 It is well known that hypertension or higher levels of BP are associated with stroke and dementia, 10, 11 and with lower levels of performance across multiple domains of cognitive function (even in the absence of stroke or dementia). [12] [13] [14] Hypertension is also known to aggregate with central obesity, hyperinsulinemia, glucose intolerance, and dyslipidemia as part of the metabolic syndrome. 15, 16 As noted previously by Elias et al., 8 it is of interest to examine whether any associations of total obesity to cognitive function might be attributable to central obesity. Central obesity has been independently associated with increased risk for stroke, 17 and is a more potent predictor of cardiovascular disease than total obesity. 18, 19 However, to our knowledge, the relation of central obesity to cognitive function has not been examined in otherwise healthy persons. Here, we examined whether, in a sample of healthy older adults who were free of stroke, dementia, and other major medical diseases, central or total obesity and BP would display interactive relations to cognitive function after controlling for other components of the metabolic syndrome. Central obesity was assessed by waist circumference (WC). WC has been suggested as the best proxy measure of central obesity 16 and it is highly correlated with visceral fat as assessed by computed tomography. 20 Total obesity was assessed by body mass index (BMI 23 The BDI and state anxiety scales were administered prior to neuropsychological testing. The trait anxiety measure was administered on a separate day.
Results
Measures of BP, WC, and BMI were correlated with other cardiovascular risk factors including other components of the metabolic syndrome (see Table 2 ). Therefore, Pearson (r) correlations were computed to examine the relations of cognitive outcome scores to these biomedical variables in addition to age, education, gender, alcohol consumption, smoking history, depressive symptoms, and state and trait anxiety scores to evaluate for potential confounders (and therefore covariates). Age, education, and gender were associated significantly (r's ¼ À0.21 to 0.48, P's o0.05) with many cognitive measures and were therefore retained as covariates in all regression models. The following significant (or marginally significant) correlations were also noted and thus used as covariates in the models involving the specific tests described below: alcohol consumption and Block Design (r ¼ 0. Multiple regression analyses were conducted for each individual cognitive outcome variable. As we were interested in determining the unique proportion of variance explained by the primary predictor variables in the multiple regression models (adjusted for all other variables in the model), we employed simultaneous entry of variables including covariates, main effects associated with the primary predictors, and the relevant interaction term. Covariates (i.e. potentially confounding variables) included in each model were age, education, and gender. In addition, any health habit (e.g. smoking, alcohol consumption), psychological variable (e.g. anxiety, depression), or biomedical variable (e.g. glucose, cholesterol) that was significantly or marginally associated with a cognitive outcome variable (as described in the prior paragraph) was included in that specific multiple regression model. For example, alcohol consumption was only used in the Block Design models. Primary predictor variables included BMI, WC, and systolic and diastolic BP. Because of the high correlation between BMI and WC (r ¼ 0.79, Po0.0001), we did not examine these variables simultaneously in any regression model due to multicollinearity. Similarly, because systolic and diastolic BP were also highly correlated (r ¼ 0.72, Po0.001), these variables were never included simultaneously in any model. Thus, four sets of multiple regression analyses were computed for each cognitive outcome -one set of multiple regression models Results of the multiple regression analyses indicated that any significant (or marginally significant) main effects of WC, BMI, and BP with respect to cognitive outcomes were all qualified by the interactions of WC (or BMI) and BP. Data associated with these interactions are depicted in Table 3 . Results of the WC and systolic BP models indicated that, after adjustment for age, education, gender, and fasting glucose, significant main effects of WC (r 2 ¼ 0. and their interaction (r 2 ¼ 0.04, P ¼ 0.06) were also noted.
With respect to the Stroop Interference score, significant main effects of BMI (r 2 ¼ 0.06, P ¼ 0.02) and diastolic BP (r 2 ¼ 0.07, P ¼ 0.01) were qualified by their interaction (r 2 ¼ 0.07, P ¼ 0.01).
To illustrate the present findings in clinically meaningful groups, we depict raw scores among individuals with high (4102 cm in men or 488 cm in women) WC versus low (o103 cm in men or o89 cm in women) WC and high (X140 mmHg) versus normal (o140 mmHg) systolic BP in 
Discussion
Results of this study indicate that, independent of other components of the metabolic syndrome and several other potential confounding factors, interactive relations of greater levels of obesity and higher BP were noted with respect to diminished performance on tests of motor speed and manual dexterity, and executive function, explaining between 3 and 11% of the variance in these measures. These relations were similar regardless of whether WC or BMI was used as an index of obesity, and whether systolic or diastolic BP were included in the models. To our knowledge, this is the first time that central obesity and its interaction with BP has been examined in relation to cognitive function. In all instances, significant main effects of obesity and BP were qualified by interactions between these two variables.
Previously, Elias et al. 8 noted independent and cumulative, negative relations of obesity and hypertension to measures of memory and executive function in male, but not female, participants in the Framingham study. Here, we did not observe gender differences, but our sample size was considerably smaller than Elias's sample. There were several other differences between these investigations. First, in the Framingham study, both BMI and BP were assessed 4-6 years prior to cognitive testing, whereas in the present investigation, they were measured concurrently. We also had the opportunity to evaluate several potential confounding variables, such as depression, VO 2 max , and glucose, insulin, and lipid levels, which were not available in the Framingham study. Chelune et al. 24 have also noted diminished executive function in morbidly obese persons. Two other populationbased studies have noted lower levels of cognitive function in the presence of obesity. 6, 7 However, these studies were limited by the presence of major confounding variables.
In the present study, we found similar relations of measures of central and total obesity with respect to cognitive function. The high correlation between these two measures in the present sample precluded their simultaneous evaluation in single regression models. It is therefore unclear whether the present findings are driven by central versus total obesity or both. These measures shared about 62% of their variance in the present sample.
Central obesity has been associated with various neuroendocrine disturbances including hypercortisolemia and low levels of sex steroid and growth hormones. 25 However, high levels of cortisol have been associated predominantly with hippocampal atrophy and impaired learning and memory function, 26 and memory was not affected in the present study. Both central and total obesity have been associated with other hormonal abnormalities such as hyperleptinemia, which has known central effects. 27 Leptin levels have been related to cognitive function. 28 These hormonal abnormalities have also been associated with enhanced sympathetic nervous system activity 25, 27 that may promote structural brain abnormalities including silent cerebrovascular disease and stroke. 29, 30 Both central and total obesity have also been associated with enhanced proinflammatory factors such as C-reactive protein, interleukin-6 and tumor necrosis factoralpha. 31, 32 Such proinflammatory factors, in turn, have been shown to exert negative effects on cognitive function. 33, 34 It is thus possible that the presence of central or total adiposity potentiates the effects of BP (or vice versa) on brain abnormalities and cognitive function. In that regard, higher Obesity, blood pressure, and cognition SR Waldstein and LI Katzel BP or hypertension has been associated with numerous plausible biological mechanisms that may lead to diminished cognitive function. These include greater white matter disease, silent brain infarction, brain atrophy, atherosclerosis in the large cerebral and cervicocerebral arteries, endothelial and cellular dysfunction, and a reduced cerebral blood flow (for a review see Waldstein and Katzel 13 ). In that regard, measures of silent cerebrovascular disease, including white matter disease, have been associated with poorer performance on cognitive tests that involve motor speed and executive function (see Gunning-Dixon and Raz 35 ), and may therefore suggest a plausible biological pathway to explain the present pattern of cognitive decrements reflecting domains of function. Limitations of this investigation include the small, and relatively homogeneous sample. This limits our statistical power and the generalizability of these findings. In addition, because our sample was limited to mild and the lower end of moderate hypertension, the range of BP was restricted. It is therefore likely that the cognitive consequences of hypertension and high BP in the general population were underestimated by this study. We chose to utilize univariate analyses in order to maximize the information unique to each cognitive test. Use of factor analysis can result in a loss of information unique to each individual cognitive test (e.g. immediate versus delayed memory, verbal versus nonverbal memory), and neuropsychological tests often load highly on two or even three factors. Nonetheless, results should be interpreted cautiously given the possibility of enhanced Type I error.
To conclude, both central and total obesity interacted with higher levels of BP to predict lower levels of performance on tests of motor speed and manual dexterity, and executive function. The present findings highlight that cardiovascular risk factors should be examined for potential interactive, negative impact on cognitive function. Preservation of cognitive function may be improved by enhanced BP control and weight loss.
